Di Gioia Jr John J MD entered the industry of Internal Medicine Doctors in 1990 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Internal Medicine Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Internal Medicine Doctors. The business provides service to the B2C market.
To acquire more information, please contact John Di Gioia Jr by calling (201) 432-5142 during business hours. You can also write to the business’ Single Location at 395 Danforth Avenue # 2, Jersey City, New Jersey NJ 07305. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Di Gioia Jr John J MD |
| Representative: | John Di Gioia Jr |
| Place of Business: | 395 Danforth Avenue # 2, Jersey City, NJ 07305 |
| Contact Number: | (201) 432-5142 |
| Type of Service: | Internal Medicine Doctors |
| SIC Number: | 8011 |
| NAICS Number: | 6211110 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 1990 |
| Income/Year: | $500.000 to $999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Di Gioia Jr John J MD is a company operating from Hudson, New Jersey providing professional Internal Medicine Doctors and relevant B2C variables. It was founded in 1990 and registered with the SIC code 8011 as Internal Medicine Doctors, and with the NAICS code 6211110 as Internal Medicine Doctors.
With a current employee count of 1 to 4, Di Gioia Jr John J MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative John Di Gioia Jr at (201) 432-5142 for related queries, or to locate its Single Location using the coordinates 40.70465,-74.09832.
The Single Location can also be found at the street address 395 Danforth Avenue # 2 in Jersey City, New Jersey 07305 and can be engaged online through the company website at , the company Twitter , and Facebook page .